Health-related quality of life in patients with basal cell nevus syndrome and high-frequency basal cell carcinoma: a questionnaire study
Clicks: 3
ID: 314877
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #239 of 313 articles by views in the british journal of dermatology
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 313 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
BACKGROUND: Multiple basal cell carcinomas (BCCs) can result from a genetic disease, such as basal cell nevus syndrome (BCNS) or develop without a genetic predisposition, known as high-frequency BCC (HF-BCC). Multiple BCCs require frequent interventions, which may impact quality of life (QoL). Data on QoL in these patients and the influence of number of BCCs on QoL remain scarce. OBJECTIVES: To evaluate QoL in patients with BCNS and HF-BCC and the impact of number of BCCs on QoL. METHODS: Patients with BCNS were recruited through the Maastricht University Medical Centre (MUMC+), the online national BCNS patient platform and through the Dutch Society for Dermatology and Venereology (NVDV). Patients with HF-BCC (≥9 BCCs in 3 years or ≥6 in 10 years) were recruited from the MUMC+ and Catharina Hospital Eindhoven. QoL was measured with the Skindex-29 and severity of QoL impact was calculated based on pre-defined cut-off scores. RESULTS: Seventy-five patients with BCNS and 59 with HF-BCC were included. Patients with BCNS were often younger (median 48 versus 74 years), 61%(46/75) were female versus 34%(20/59) of patients with HF-BCC, and 48%(36/75) had > 100 BCCs versus 1.7%(1/59) of HF-BCC patients. A substantial proportion of patients with BCNS reported severe impact on emotions and functioning (36.0%(27/75) and 22.7%(17/75), respectively) and mean scores of 32.2±20.8 and 18.9±19.6 respectively. Adjusting for age and sex, the overall Skindex-29 score was higher in the BCNS group, with a between group difference of 10 (95% CI 2.5-17.5). Among patients with BCNS, BCC burden was negatively associated with QoL, with significantly higher scores in patients with >100 compared to <30 BCCs (mean total score of 32.0±19.6 versus 15.8±11.6). This trend was not observed in HF-BCC. CONCLUSIONS: These findings highlight an increased QoL impairment in patients with BCNS compared to others with multiple BCCs, especially with respect to emotional and functional well-being. This can be partly explained by the high BCC burden in this patient group. Our findings suggest that a high BCC burden is an indicator of psychosocial burden, and underscores that disease-related challenges in emotional and social domains should be considered during consultations to improve patient support.
| Reference Key |
openalex_W7162284797
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Anna A L Massella Patsea, Myrthe M G Moermans, Babette J A Verkouteren, Patty J. Nelemans, Aimée H M M Arits, Marlies Wakkee, Emoke Racz, Marcel Bekkenk, Klara Mosterd |
| Journal | the british journal of dermatology |
| Year | 2026 |
| DOI |
10.1093/bjd/ljag212
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.